Granza Bio

Granza Bio is a biotechnology company focused on reprogramming immunity to develop target-specific medicines. The company is built on the groundbreaking discovery of 'attack particles,' which are autonomous killing entities released from cytotoxic immune cells. This innovative approach is rooted in research conducted in the lab of co-founder Prof. Dustin at the University of Oxford, emphasizing a scientific foundation for its therapeutic strategies. Granza Bio aims to leverage this discovery to enhance treatment options for various diseases, including cancers, autoimmunity, and infections.

Th…